{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:30:27Z","timestamp":1760131827540},"reference-count":23,"publisher":"Hindawi Limited","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3280,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01109.x","type":"journal-article","created":{"date-parts":[[2006,9,8]],"date-time":"2006-09-08T21:28:26Z","timestamp":1157750906000},"page":"1330-1334","source":"Crossref","is-referenced-by-count":7,"title":["Transdermal buprenorphine in pain management - experiences from clinical practice: five case studies"],"prefix":"10.1155","volume":"60","author":[{"given":"F.","family":"LOUIS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2006,9,8]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3959(86)90091-6","article-title":"Chronic use of opioid analgesics in non-malignant pain: report of 38 cases","volume":"25","author":"Portenoy","year":"1986","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00003495-199142020-00005","article-title":"Treatment principles for the use of opioids in pain of nonmalignant origin","volume":"42","author":"Schug","year":"1991","journal-title":"Drugs"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0885-3924(92)90116-Y","article-title":"Long-term oral opioid therapy in patients with chronic nonmalignant pain","volume":"7","author":"Zenz","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/bja\/87.1.133","article-title":"Chronic opioid therapy for non-cancer pain","volume":"87","author":"Collett","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB5|cit5","first-page":"6","article-title":"The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society","volume":"13","year":"1997","journal-title":"Clin J Pain"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB6|cit6","first-page":"688","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1163\/156856903321579334","article-title":"Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study","volume":"15","author":"B\u00f6hme","year":"2003","journal-title":"Pain Clin"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0149-2918(03)90019-1","article-title":"Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"25","author":"Sittl","year":"2003","journal-title":"Clin Ther"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.clinthera.2004.11.008","article-title":"Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study","volume":"26","author":"Sorge","year":"2004","journal-title":"Clin Ther"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1185\/030079905X53315","article-title":"Transdermal buprenorphine in clinical practice - a post-marketing surveillance study in 13,179 patients","volume":"21","author":"Griessinger","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3959(88)90198-4","article-title":"Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain","volume":"33","author":"Arn\u00e9r","year":"1988","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB12|cit12","first-page":"307","volume-title":"Opioid Sensitivity of Chronic Noncancer Pain","volume":"14","author":"Rowbotham","year":"1999"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(96)09024-1","article-title":"Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain","volume":"349","author":"Dellemijn","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","article-title":"Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy","volume":"50","author":"Harati","year":"1998","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3959(99)00079-2","article-title":"Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa021420","article-title":"Oral opioid therapy for chronic peripheral and central neuropathic pain","volume":"348","author":"Rowbotham","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1191\/096813099669853099","article-title":"Signal transduction in neuropathic pain, with special emphasis on the analgesic role of opioids. Part II: moving basic science towards a new pharmacotherapy","volume":"6","author":"McCormack","year":"1999","journal-title":"Pain Rev"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2044.1981.tb08867.x","article-title":"High dose buprenorphine for postoperative analgesia","volume":"36","author":"Budd","year":"1981","journal-title":"Anaesthesia"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB19|cit19","first-page":"235","article-title":"New perspectives on the pharmacology of opioids and their use in chronic pain","volume":"16","author":"Staats","year":"2002","journal-title":"Prog Anaesthesiol"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB20|cit20","first-page":"51","article-title":"Experience with partial agonist in the treatment of cancer pain","volume":"146","author":"Budd","year":"1990","journal-title":"R Soc Med Serv Int Congr Symp"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2165\/00003495-200363190-00003","article-title":"Transdermal buprenorphine","volume":"63","author":"Evans","year":"2003","journal-title":"Drugs"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB22|cit22","first-page":"1127","article-title":"Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation","volume":"292","author":"Zaki","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1742-1241.2006.01109.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clinthera.2005.02.012","article-title":"Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study","volume":"27","author":"Sittl","year":"2005","journal-title":"Clin Ther"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01109.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01109.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:04:50Z","timestamp":1643349890000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01109.x"}},"subtitle":["TRANSDERMAL BUPRENORPHINE IN PAIN MANAGEMENT"],"short-title":[],"issued":{"date-parts":[[2006,9,8]]},"references-count":23,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01109.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9,8]]}}}